NASDAQ:SANA

Sana Biotechnology Stock Forecast, Price & News

$25.51
+1.31 (+5.41 %)
(As of 04/14/2021 12:54 PM ET)
Add
Compare
Today's Range
$24.33
Now: $25.51
$26.43
50-Day Range
$23.04
MA: $30.42
$37.85
52-Week Range
$21.21
Now: $25.51
$44.60
Volume9,919 shs
Average Volume666,329 shs
Market Capitalization$4.78 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops in vivo and ex vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Sana Biotechnology logo

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SANA
CUSIPN/A
CIKN/A
Phone206 701 7914
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$4.78 billion
Next Earnings Date6/23/2021 (Estimated)
OptionableNot Optionable

Headlines

Sana Biotechnology (NASDAQ:SANA) Trading 8.2% Higher
April 14, 2021 |  americanbankingnews.com
Sana Biotechnology (NASDAQ:SANA) Shares Down 10.7%
April 12, 2021 |  americanbankingnews.com
Sana Biotechnology (NASDAQ:SANA) Sees Large Volume Increase
April 6, 2021 |  americanbankingnews.com
Sana Biotechnology (NASDAQ:SANA) Trading Down 4.2%
April 1, 2021 |  americanbankingnews.com
Sana Biotechnology (NASDAQ:SANA) Sees Strong Trading Volume
March 31, 2021 |  americanbankingnews.com
Sana Biotechnology Inc Registered Shs Overweight
March 3, 2021 |  markets.businessinsider.com
Sana Biotechnology Inc Registered Shs Neutral
March 3, 2021 |  markets.businessinsider.com
Sana Biotechnology Inc
February 20, 2021 |  reuters.com
Sana Biotechnology: An Ultra-Risky Bet
February 10, 2021 |  seekingalpha.com
See More Headlines

MarketRank

Overall MarketRank

1.15 out of 5 stars

Medical Sector

957th out of 2,019 stocks

Biotechnology Industry

37th out of 145 stocks

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$25.51
+1.31 (+5.41 %)
(As of 04/14/2021 12:54 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SANA News and Ratings via Email

Sign-up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sana Biotechnology (NASDAQ:SANA) Frequently Asked Questions

Is Sana Biotechnology a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sana Biotechnology in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sana Biotechnology stock.
View analyst ratings for Sana Biotechnology
or view top-rated stocks.

What stocks does MarketBeat like better than Sana Biotechnology?

Wall Street analysts have given Sana Biotechnology a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sana Biotechnology wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sana Biotechnology's next earnings date?

Sana Biotechnology is scheduled to release its next quarterly earnings announcement on Wednesday, June 23rd 2021.
View our earnings forecast for Sana Biotechnology
.

How were Sana Biotechnology's earnings last quarter?

Sana Biotechnology, Inc. (NASDAQ:SANA) issued its quarterly earnings data on Tuesday, March, 23rd. The company reported ($2.98) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $2.57.
View Sana Biotechnology's earnings history
.

What price target have analysts set for SANA?

4 analysts have issued 1-year target prices for Sana Biotechnology's shares. Their forecasts range from $35.00 to $45.00. On average, they expect Sana Biotechnology's share price to reach $40.00 in the next twelve months. This suggests a possible upside of 57.7% from the stock's current price.
View analysts' price targets for Sana Biotechnology
or view top-rated stocks among Wall Street analysts.

Who are Sana Biotechnology's key executives?

Sana Biotechnology's management team includes the following people:
  • Dr. Steven D. Harr, Pres, CEO & Director (Age 51, Pay $535k)
  • Dr. Richard C. Mulligan, Exec. Vice Chairman & Head of SanaX (Age 66, Pay $756.45k)
  • Mr. Christian Hordo M.B.A., Sr. VP & Chief Bus. Officer (Age 38, Pay $350.2k)
  • Mr. Nathan Hardy M.B.A., Sr. VP & CFO (Age 45)
  • Ms. Shanna Clouse Peek, Sr. VP & Head of Corp. Operations
  • Brittany Mccleery, Accounting Mang.
  • Dr. Edward Rebar Ph.D., Sr. VP & CTO (Age 53)
  • Mr. James J. MacDonald J.D., Exec. VP, Gen. Counsel & Sec. (Age 46)
  • Ms. Robin Andrulevich, Exec. VP & Chief People Officer (Age 55)
  • Dr. Sunil Agarwal, Exec. VP, Head of Devel. & Chief Medical Officer (Age 51)

Who are some of Sana Biotechnology's key competitors?

When did Sana Biotechnology IPO?

(SANA) raised $322 million in an initial public offering (IPO) on Thursday, February 4th 2021. The company issued 15,000,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and BofA Securities acted as the underwriters for the IPO.

What is Sana Biotechnology's stock symbol?

Sana Biotechnology trades on the NASDAQ under the ticker symbol "SANA."

When does the company's lock-up period expire?

Sana Biotechnology's lock-up period expires on Tuesday, August 3rd. Sana Biotechnology had issued 23,500,000 shares in its initial public offering on February 4th. The total size of the offering was $587,500,000 based on an initial share price of $25.00. After the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of Sana Biotechnology?

Shares of SANA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sana Biotechnology's stock price today?

One share of SANA stock can currently be purchased for approximately $25.37.

How much money does Sana Biotechnology make?

Sana Biotechnology has a market capitalization of $4.76 billion.

What is Sana Biotechnology's official website?

The official website for Sana Biotechnology is sana.com.

How can I contact Sana Biotechnology?

The company can be reached via phone at 206 701 7914.


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.